Abstract
Medicare does not reimburse for home infusion; patients requiring outpatient parenteral antimicrobial therapy must seek treatment in high-risk settings. We recommend policy change to allow for adequate social distancing during the coronavirus disease 2019 pandemic.
Original language | English (US) |
---|---|
Pages (from-to) | 3250-3251 |
Number of pages | 2 |
Journal | Clinical Infectious Diseases |
Volume | 71 |
Issue number | 12 |
DOIs | |
State | Published - Dec 15 2020 |
Keywords
- CMS
- COVID-19
- Health Insurance Policy
- OPAT
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases